Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 2014 Apr 8;51(5):248–254. doi: 10.1007/s00262-002-0275-5

Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression

Shanshan Wu 1, George A Murrell 2, Yao Wang 1
PMCID: PMC11032973  PMID: 12070711

Abstract

The regulation of urokinase plasminogen activator receptor (uPAR) gene expression by interferon-alpha (IFN-α, or Intron A) and interferon-gamma (IFN-γ) was studied in a HCT116 colon cancer cell line. uPAR mRNA levels were increased in a dose- and time-dependent manner in cells stimulated with IFN-α or IFN-γ. uPAR protein levels reflected IFN-α and IFN-γ induction of uPAR mRNA production. Cycloheximide, a protein synthesis inhibitor, also induced uPAR mRNA accumulation either alone or in combination with IFN-α or IFN-γ, suggesting that the effect on uPAR mRNA levels activated by IFN-α or IFN-γ does not require de novo protein synthesis. Both sodium butyrate and amiloride inhibited the uPAR mRNA levels induced by IFN-α or IFN-γ. These results may provide useful information for the treatment of patients receiving IFN-α or IFN-γ.

Keywords: Colon cancer cell Gene expression Interferon (IFN) Urokinase-type plasminogen activator receptor (uPAR)

Footnotes

Electronic Publication


Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES